コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 alizations, 222 cardiovascular deaths, and 6 aborted cardiac arrests).
2 lar death, heart failure hospitalization, or aborted cardiac arrest.
3 cardiovascular death, HF hospitalization, or aborted cardiac arrest.
4 had at least 1 recurrence: 0 patients had an aborted cardiac arrest, 2 patients had syncope only, 10
9 ngation, and sex were predictive of risk for aborted cardiac arrest and sudden cardiac death during a
13 ted to the risk for cardiac events (syncope, aborted cardiac arrest, and sudden cardiac death) among
14 an adverse cardiac event, including syncope, aborted cardiac arrest, and sudden death, during and aft
16 rs for a severe arrhythmic events comprising aborted cardiac arrest, appropriate implantable cardiove
17 ed as LQTS-attributable syncope or seizures, aborted cardiac arrest, appropriate ventricular fibrilla
19 rdiac death; 9 of the 81 patients who had an aborted cardiac arrest event experienced subsequent sudd
20 HF hospitalization, cardiovascular death, or aborted cardiac arrest in HFpEF independent of clinical
21 re hospitalization, cardiovascular death, or aborted cardiac arrest independent of clinical and labor
22 ospitalization, cardiovascular mortality, or aborted cardiac arrest), its components, and all-cause m
23 ure and death (n = 4), sudden death (n = 1), aborted cardiac arrest (n = 1), or heart transplantation
25 versus unaffected adjusted hazard ratio for aborted cardiac arrest or death was 2.65 (P<0.001) in th
26 zard ratio of 12.9 (95% CI, 4.7 to 35.5) for aborted cardiac arrest or death while on prescribed beta
27 tality or ventricular arrhythmia, defined as aborted cardiac arrest or documented ventricular fibrill
28 ons was associated with the highest risk for aborted cardiac arrest or sudden cardiac death (hazard r
29 gnificantly greater reduction in the risk of aborted cardiac arrest or sudden cardiac death among pat
31 deling was used to identify risk factors for aborted cardiac arrest or sudden cardiac death in 3015 L
32 a comprehensive analysis of risk factors for aborted cardiac arrest or sudden cardiac death in pre-sp
33 9.1) for recurrent cardiac events (syncope, aborted cardiac arrest, or death) during beta-blocker th
34 osite outcome (time to cardiovascular death, aborted cardiac arrest, or hospitalization for managemen
35 outcome of death from cardiovascular causes, aborted cardiac arrest, or hospitalization for the manag
36 mposite of death from cardiovascular causes, aborted cardiac arrest, or hospitalization for the manag
37 vents arrhythmic events (arrhythmic syncope, aborted cardiac arrest, or sudden cardiac death) in LQT3
39 ty and lethality of cardiac events (syncope, aborted cardiac arrest, or sudden death) occurring from
40 The probability of cardiac events (syncope, aborted cardiac arrest, or sudden death) was analyzed by
42 0 [p < 0.0001]) and life-threatening events (aborted cardiac arrest/sudden cardiac death: 27% per 10-
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。